Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin in non-constipation irritable bowel syndrome
NCT00731679Phase 3Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Jul 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of rifaximin in irritable bowel syndrome (IBS), sponsored by Valeant Pharmaceuticals. Started Jul 2008; status: completed.
02
Drugs
rifaximin
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT00731679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00731679.